NCT06398002View on ClinicalTrials.gov

The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2025

Conditions
Secondary HyperparathyroidismEnd-stage Kidney Disease
Interventions
OTHER

Dialysate calcium 1.50 mmol/L

Increased dialysate calcium of 1.50 mmol/L (as compared to standard dialysate calcium of 1.25 mmol/L)

All Listed Sponsors
lead

Iain Bressendorff

OTHER